T3 Companies, LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 2052441 NEW YORK, NY

Position in ESPR

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$260,700

New position

Shares Held

82,500

first reported quarter

Ownership

0.032%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#9

of 40 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

T3 Companies, LLC holds $7,960,424 across 5 Drug Manufacturers - Specialty & Generic names. ESPR ranks #3 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	87,800	$7,000,294
2	NBIX	Neurocrine Biosciences Inc	2,000	$337,080
3	ESPR	Esperion Therapeutics, Inc. This page	82,500	$260,700
4	HROW	Harrow, Inc.	5,000	$212,350
5	BCRX	Biocryst Pharmaceuticals Inc	15,000	$150,000

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$260,700	82,500	—	Shares	Sole	2026-07-27
No filing history on record for this holder in this stock.